Last reviewed · How we verify

NCT06566287

Immediate and Delayed Implant Placement Using Socket Shield Technique and Autogenous Dentin Graft

Completed NA Last updated 22 August 2024
What this trial tests

NA trial testing Immediate implant in Dental Implant in 22 participants. Completed in 19 December 2023.

Timeline
17 January 2023
Primary endpoint
19 December 2023
19 December 2023

Quick facts

Lead sponsorHams Hamed Abdelrahman
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment22
Start date17 January 2023
Primary completion19 December 2023
Estimated completion19 December 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Hams Hamed Abdelrahman — full company profile →

Who can join

Adults 18 to 50, any sex, with Dental Implant or Tooth Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

One of the techniques that have been proposed to reduce the amount of bone resorption in anterior maxilla is the "socket shield (SS) ". This technique includes preservation of the facial segment of a root to be extracted and immediate implant placement. A technique of socket shield with delayed implantation using autogenous dentin graft for socket preservation, as an alternative to autogenous bone grafts, has shown predictable clinical and histological outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Immediate implant

Trials testing the same drug.

Other recruiting trials for Dental Implant

Currently open trials in the same condition.

Other Hams Hamed Abdelrahman trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06566287.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing